Locate Bio Ltd (Locate), formerly RegenTec Ltd is a regenerative medicine development company that concentrates on drug delivery and tissue scaffold capabilities. The company develop its products for low back pain, and orthopedic biofilm infections. Locate provides clinical treatments throughout the body including orthopedic medicine, cell therapy, drug delivery, cell culture and veterinary medicine. The company promotes activities of receptor-binding moieties, locally applied drugs, and emergent biological and cell-based therapies. It serves pharmaceutical and biopharmaceutical companies. Locate is headquartered in Beeston, the UK.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
The report analyzes all pipeline products in development for the company Locate Bio Ltd
The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
The report provides detailed description of products in development, technical specification and functions
The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
To formulate effective Research & Development strategies
Develop market-entry and market expansion strategies
Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note:Some sections may be missing if data is unavailable for the company
Locate Bio Ltd Company Overview
Locate Bio Ltd Company Snapshot
Locate Bio Ltd Pipeline Products and Ongoing Clinical Trials Overview
Locate Bio Ltd – Pipeline Analysis Overview
Locate Bio Ltd - Key Facts
Locate Bio Ltd - Major Products and Services
Locate Bio Ltd Pipeline Products by Development Stage
Locate Bio Ltd Ongoing Clinical Trials by Trial Status
Locate Bio Ltd Pipeline Products Overview
Chondro3
Chondro3 Product Overview
CognitOss
CognitOss Product Overview
Ldgraft
Ldgraft Product Overview
Ldgraft Clinical Trial
Locate Bio Ltd - Key Competitors
Locate Bio Ltd - Key Employees
Locate Bio Ltd - Locations And Subsidiaries
Head Office
Recent Developments
Locate Bio Ltd, Recent Developments
May 18, 2023: Locate Bio’s LDGraft granted FDA breakthrough device designation
Feb 24, 2021: Locate Bio’s Chondro3 granted FDA Breakthrough Device Designation
Jan 07, 2021: FDA grants breakthrough device designation to Locate Bio’s CognitOss
Nov 26, 2018: Locate Bio names Dr Nick Staples as chief executive officer
Oct 16, 2018: Locate Therapeutics announces name change to Locate Bio and new investment from mercia technologies plc
Jan 18, 2018: Locate Therapeutics Achieves ISO 13845 Certification
Jan 05, 2015: Locate Therapeutics Appoints Chairman to its Board of Directors
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Table 1: Locate Bio Ltd Pipeline Products and Ongoing Clinical Trials Overview
Table 2: Locate Bio Ltd Pipeline Products by Equipment Type
Table 3: Locate Bio Ltd Pipeline Products by Indication
Table 4: Locate Bio Ltd, Key Facts
Table 5: Locate Bio Ltd, Major Products and Services
Table 6: Locate Bio Ltd Number of Pipeline Products by Development Stage
Table 7: Locate Bio Ltd Pipeline Products Summary by Development Stage
Table 8: Locate Bio Ltd Ongoing Clinical Trials by Trial Status
Table 9: Locate Bio Ltd Ongoing Clinical Trials Summary
Table 10: Chondro3 - Product Status
Table 11: Chondro3 - Product Description
Table 12: CognitOss - Product Status
Table 13: CognitOss - Product Description
Table 14: Ldgraft - Product Status
Table 15: Ldgraft - Product Description
Table 16: Ldgraft - A Study to Evaluate the Efficacy of LDGraft in Subjects Who Require Surgery for Chronic Lower Back Pain
Table 17: Locate Bio Ltd, Key Employees
Table 18: Glossary
List of Figures
Figure 1: Locate Bio Ltd Pipeline Products by Equipment Type
Figure 2: Locate Bio Ltd Pipeline Products by Development Stage
Figure 3: Locate Bio Ltd Ongoing Clinical Trials by Trial Status